Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease IN RESPONSE

被引：1
|
作者：
Schechter, Meir [1 ,2 ,3 ]
Chertow, Glenn M. [4 ,5 ]
Heerspink, Hiddo J. L. [1 ,6 ]
机构：
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands
[2] Hadassah Med Ctr, Diabet Unit, Dept Endocrinol & Metab, Jerusalem, Israel
[3] Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel
[4] Stanford Univ, Dept Med, Sch Med, Stanford, CA USA
[5] Stanford Univ, Dept Epidemiol & Populat Hlth, Sch Med, Stanford, CA USA
[6] George Inst Global Hlth, Sydney, NSW, Australia
来源：
ANNALS OF INTERNAL MEDICINE | 2023年 / 176卷 / 07期
关键词：
D O I：
10.7326/L23-0070
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：1
相关论文
共 50 条
  • [31] DAPAGLIFLOZIN - NEW SOLUTION IN CHRONIC KIDNEY DISEASE TREATMENT
    Bara, Maciej
    Starownik, Jakub
    Szydlo, Jakub
    Gryszkiewicz, Patryk
    Nieznanski, Jakub
    [J]. PROSPECTS IN PHARMACEUTICAL SCIENCES, 2024, 22 (02): : 59 - 64
  • [32] Dapagliflozin: reduced diabetes incidence in chronic kidney disease?
    Simon, Annika
    [J]. DIABETOLOGIE UND STOFFWECHSEL, 2022, 17 (02)
  • [33] Correlation between Hyperkalemia and the Duration of Several Hospitalizations in Patients with Chronic Kidney Disease
    Calabrese, Vincenzo
    Cernaro, Valeria
    Battaglia, Valeria
    Gembillo, Guido
    Longhitano, Elisa
    Siligato, Rossella
    Sposito, Giovanna
    Ferlazzo, Guido
    Santoro, Domenico
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (01)
  • [34] Effect of Dapagliflozin on Serum Uric Acid Levels in Patients with Advanced Chronic Kidney Disease
    Mori, Daisuke
    Kobayashi, Midori
    Wada, Masafumi
    Tokuchi, Maho
    Misegawa, Soichiro
    Saito, Rina
    Nomi, Hiroki
    Haga, Ryota
    Nagatoya, Katsuyuki
    Yamauchi, Atsushi
    [J]. INTERNAL MEDICINE, 2024, 63 (03) : 353 - 357
  • [35] COST-UTILITY ANALYSIS OF DAPAGLIFLOZIN IN PATIENTS WITH CHRONIC KIDNEY DISEASE IN DOMINICAN REPUBLIC
    Ordonez, J.
    Dina, E.
    Alvarez, G.
    Rojas, L.
    Ordonez, A.
    Hidalgo Godinez, J.
    Villalobos, K.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S341 - S341
  • [36] COST-UTILITY ANALYSIS OF DAPAGLIFLOZIN IN PATIENTS WITH CHRONIC KIDNEY DISEASE IN COSTA RICA
    Ordonez, J.
    Hernandez, F.
    Rodriguez, G.
    Estrada, J.
    Ordonez, A.
    Hidalgo Godinez, J.
    Villalobos, K.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S403 - S403
  • [37] Management of chronic kidney disease and its cardiovascular complications: has the dawn of a new era arrived? Comment on 'Dapagliflozin in Patients with Chronic Kidney Disease'
    Liuzzo, Giovanna
    Patrono, Carlo
    [J]. EUROPEAN HEART JOURNAL, 2020, 41 (44) : 4231 - 4232
  • [38] Effects of Dapagliflozin on EChOcardiographic Measures of CarDiac StructurE and Function in Patients with Chronic Kidney Disease: The DECODE-CKD Trial
    Bartholdy, Katja Vu
    Johansen, Niklas Dyrby
    Landler, Nino
    Skaarup, Kristoffer Grundtvig
    Jensen, Jesper
    Bressendorff, Iain
    Schou, Morten
    Christensen, Jacob
    Feldt-Rasmussen, Bo
    Vaduganathan, Muthiah
    Solomon, Scott
    Haynes, Richard
    Persson, Frederik
    Rossing, Peter
    Kober, Lars
    Zannad, Faiez
    Hansen, Ditte
    Biering-Sorensen, Tor
    [J]. KIDNEY360, 2023, 4 (02): : 143 - 149
  • [39] Rates of Gastrointestinal Hospitalizations in Adults With Chronic Kidney Disease
    Haider, Mahnur
    Baudier, Robin L.
    Batuman, Vecihi
    Srivastava, Anand
    Weir, Matthew
    Anderson, Amanda H.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S1062 - S1063
  • [40] EARLY DAPAGLIFLOZIN UTILIZATION FOR CHRONIC KIDNEY DISEASE TREATMENT IN JAPAN
    Sofue, Tadashi
    Takeda, Masayoshi
    Koto, Ryo
    Wright, Jason
    Hong, Lai San
    Nan, Cassandra
    Wittbrodt, Eric
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I514 - I514
12345